Intelligent Bio Solutions Inc. (INBS) FCF Margin (2020 - 2025)
Intelligent Bio Solutions (INBS) posted quarterly FCF Margin of 380.01% for Q1 2025, down 8334.0% year-over-year from 4.62% in Q1 2024, and up 0.7% quarter-over-quarter from 382.68% in Q4 2024.
Intelligent Bio Solutions Inc. (INBS) FCF Margin (2020 - 2025) Analysis & Trends
Intelligent Bio Solutions' FCF Margin history runs 6 years deep, the most recent figure standing at 380.01% for Q1 2025.
- In Q1 2025, FCF Margin fell 8334.0% year-over-year to 380.01%; the TTM figure through Mar 2025 stood at 246.72% (up 829.0% YoY), while the FY2023 annual figure was 586.96%, down 37229.0% from the prior year.
- FCF Margin for Q1 2025 stood at 380.01%, up from 382.68% in the prior quarter.
- The five-year high for FCF Margin was 131.86% in Q2 2023, with the low at 17962.77% in Q1 2021.
- The 5-year median for FCF Margin is 375.51% (2023), against an average of 1542.78%.
- The sharpest annual moves came in 2021 and 2022: FCF Margin plunged 369982 bps in 2021, then jumped 1781097 bps in 2022.
- Intelligent Bio Solutions' FCF Margin stood at 801.82% in 2021, then rose by 17 bps to 667.5% in 2022, then soared by 44 bps to 375.51% in 2023, then declined by 2 bps to 382.68% in 2024, then rose by 1 bps to 380.01% in 2025.
- Business Quant data shows INBS's FCF Margin at 380.01% in Q1 2025, 382.68% in Q4 2024, and 273.67% in Q3 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -380.01% |
| Dec 31, 2024 | -382.68% |
| Sep 30, 2024 | -273.67% |
| Mar 31, 2024 | -296.68% |
| Dec 31, 2023 | -375.51% |
| Sep 30, 2023 | -164.78% |
| Jun 30, 2023 | -131.86% |
| Mar 31, 2023 | -551.01% |
| Dec 31, 2022 | -667.50% |
| Sep 30, 2022 | -544.98% |
| Jun 30, 2022 | -144.33% |
| Mar 31, 2022 | -151.80% |
| Dec 31, 2021 | -801.82% |
| Jun 30, 2021 | -312.24% |
| Mar 31, 2021 | -17,962.77% |
| Dec 31, 2020 | -274.51% |
| Sep 30, 2020 | -4,830.25% |
| Jun 30, 2020 | 282.57% |
| Mar 31, 2020 | -14,262.95% |